The estimated Net Worth of Adriana Karaboutis is at least $1.31 Milione dollars as of 14 May 2024. Ms. Karaboutis owns over 8,764 units of Perrigo plc stock worth over $713,317 and over the last 10 years she sold PRGO stock worth over $210,235. In addition, she makes $384,483 as Independent Director at Perrigo plc.
Sign up
Ms. Karaboutis PRGO stock SEC Form 4 insiders trading
Adriana has made over 17 trades of the Perrigo plc stock since 2015, according to the Form 4 filled with the SEC. Most recently she exercised 8,764 units of PRGO stock worth $264,848 on 14 May 2024.
The largest trade she's ever made was exercising 8,764 units of Perrigo plc stock on 14 May 2024 worth over $264,848. On average, Adriana trades about 861 units every 53 days since 2014. As of 14 May 2024 she still owns at least 26,686 units of Perrigo plc stock.
You can see the complete history of Ms. Karaboutis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Adriana Karaboutis biography
Adriana (Andi) Karaboutis is Independent Director at Perrigo Company Public Limited Company. Ms. Karaboutis has served as Chief Information and Digital Officer of National Grid, a publicly traded utility company. Ms. Karaboutis served as Executive Vice President, Technology, Business Solutions and Corporate Affairs at Biogen Inc., an independent biotechnology company from December 2015 to February 2017, and as Executive Vice President, Technology and Business Solutions from September 2014 to December 2015. Prior to that, Ms. Karaboutis served as Vice President and Global Chief Information Officer of Dell, Inc., a global technology company, from 2011 to September 2014, and as Vice President of IT, Global Operations and Technology from 2010 to 2011. Ms. Karaboutis spent more than 20 years at General Motors Corporation and Ford Motor Company in various leadership positions, including computer-integrated manufacturing, supply chain operations and information technology. Ms. Karaboutis has been a director of Advance Auto Parts, Inc. since 2015 but as announced on March 4, 2020 she will not be standing for re-election to the Advance Auto Parts board at its May 2020 AGM. Pursuant to a press release dated March 4, 2020, Aspen Technologies, a global leader in optimization software, has appointed Ms. Karaboutis to its board beginning in July 2020. Ms. Karaboutis served on the board of directors of Blue Cross Blue Shield of Massachusetts from February 2016 to December 2017
What is the salary of Adriana Karaboutis?
As the Independent Director of Perrigo plc, the total compensation of Adriana Karaboutis at Perrigo plc is $384,483. There are 18 executives at Perrigo plc getting paid more, with Murray Kessler having the highest compensation of $10,807,800.
How old is Adriana Karaboutis?
Adriana Karaboutis is 57, she's been the Independent Director of Perrigo plc since 2017. There are 17 older and 10 younger executives at Perrigo plc. The oldest executive at Perrigo Company plc is Rolf Classon, 75, who is the Independent Director.
What's Adriana Karaboutis's mailing address?
Adriana's mailing address filed with the SEC is 200 EAST RANDOLPH ST., , CHICAGO, IL, 60601.
Insiders trading at Perrigo plc
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen e Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
What does Perrigo plc do?
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
What does Perrigo plc's logo look like?
Complete history of Ms. Karaboutis stock trades at Aspen Technology Inc, Biogen Inc, Advance Auto Parts Inc, Aon plc e Perrigo plc
Perrigo plc executives and stock owners
Perrigo plc executives and other stock owners filed with the SEC include:
-
Murray Kessler,
President, Chief Executive Officer, Director -
Raymond Silcock,
Chief Financial Officer, Executive Vice President -
Murray S. Kessler,
CEO, Pres & Director -
Todd Kingma,
Executive Vice President, General Counsel, Company Secretary -
James Dillard,
Executive Vice President, Chief Scientific Officer -
Svend Andersen,
Executive Vice President, President - Consumer Healthcare International -
Sharon Kochan,
Executive Vice President, President - RX Pharmaceuticals -
Raymond P. Silcock,
CFO, Principal Accounting Officer & Exec. VP -
Svend Andersen,
Exec. VP & Pres of Consumer Healthcare International -
Richard S. Sorota,
Exec. VP & Pres of Consumer Self-Care Americas -
Todd W. Kingma,
Exec. VP, Gen. Counsel & Sec. -
James E. Dillard III,
Exec. VP & Pres of Consumer Self-Care Americas -
Rolf Classon,
Independent Director -
Donal O'Connor,
Independent Director -
Jeffrey Kindler,
Independent Director -
Theodore Samuels,
Independent Director -
Geoffrey Parker,
Independent Director -
Bradley Alford,
Independent Director -
Adriana Karaboutis,
Independent Director -
Erica Mann,
Independent Director -
Bradley Joseph,
Vice President Global Investor Relations -
Katherine Doyle,
Director -
Rich Sorota,
Executive Vice President and President - Consumer Self-Care Americas -
Grainne Quinn,
Executive Vice President, Chief Medical Officer -
Ronald Janish,
Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer -
Thomas Farrington,
Executive Vice President, Chief Information Officer -
Robert Willis,
Chief Human Resource Officer, Executive Vice President -
Kyle L. Hanson,
Exec. VP, Gen. Counsel & Corp. Sec. -
Alison Ives,
Exec. VP & Chief Scientific Officer -
Eduardo Guarita Bezerra,
Exec. VP & CFO -
Mary Reilly-Brest,
Director of Global Organizational and Human Resource Devel. -
Thomas M. Farrington,
Chief Information Officer & Exec. VP -
Shannon Hukill,
Sr. Director of Technical Operations -
Ronald C. Janish,
Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain -
Patrick Lockwood Taylor,
CEO -
Paul Weninger,
EVP, Quality Operations -
James R Michaud,
EVP, Chief HR Officer -
John T Hendrickson,
EVP Global Operations & Supply -
Gary M Cohen,
Director -
John Wesolowski,
EVP, President Rx -
Michael J Jandernoa,
Director -
Judy L Brown,
Executive VP & CFO -
Laurie Brlas,
Director -
Jeffrey C Smith,
Director -
Triona Schmelter,
EVP & President CSCA -
Uwe Roehrhoff,
CEO -
Ronald Winowiecki,
CFO -
David Ball,
EVP & CBDO -
Jacqualyn A Fouse,
Director -
Ellen Randi Hoffing,
Director -
Louis Yu,
Executive VP Global Quality -
Shlomo Yanai,
Director -
Marc Coucke,
Executive VP & GM -
Michael Robert Stewart,
Sr. VP Global Human Resources -
Joseph C Papa,
President and CEO -
Gary K Jr Kunkle,
Director -
Herman Jr Morris,
Director -
Ben Zion Zilberfarb,
Director -
Ran Gottfried,
Director -
Jatin Shah,
Sr VP & Chief Scientific Offic -
Scott F Jamison,
-
David T Gibbons,
Director -
Douglas Boothe,
EVP & GM Perrigo Pharma -
Jeffrey Needham,
EVP, President CHC Americas -
Orlando D Ashford,
Director -
Alison Ives,
EVP & Chief Scientific Officer -
Kyle Hanson,
EVP & General Counsel -
Eduardo Guarita Bezerra,
EVP & Chief Financial Officer -
Albert Manzone,
Director -
Julia M Brown,
Director